‘Safe and Effective’: New CDC Data Reveals Information on JYNNEOS Mpox Vaccine

‘Safe and Effective’: New CDC Data Reveals Information on JYNNEOS Mpox Vaccine

More than 29,000 cases of mpox, formerly known as monkeypox, have been reported in the U.S.

New data from two recently published studies from the Center for Disease Control and Prevention (CDC) show that the JYNNEOS mpox vaccine is both “safe” and “effective,” the agency said.

According to a media statement, the first report, published on December 9, found that although there were some side effects—like dizziness or pain at the location of the vaccine—to the JYNNEOS mpox vaccine, there were “no major vaccine safety concerns” after about one million vaccines were provided.

In the second report, also published on December 9, researchers looked at the rate of mpox illness between unvaccinated and vaccinated people. In people who only had one of the two mpox doses, rates were 7.4 times higher than fully vaccinated people. The rate increased for those who were completely unvaccinated to 9.6.

“Mpox cases are decreasing, but so is public concern,” said Jonathan Mermin, M.D., M.P.H., mpox response Incident Manager in the media statement. “With a safe, effective vaccine in our hands, this is our chance to turn the page and finish strong.”

As of December 7, there were 29,711 cases of mpox, previously called monkeypox, in the U.S. Most of the cases were reported in California, 5,604, and New York, 4,180, with Texas, Florida and Georgia also reporting high numbers.

The CDC provides guidance on the prevention of the virus in some workplace settings. Healthcare personnel should correctly use PPE. For those who work in a setting where people share housing, the CDC has various guidelines on responding to positive cases. Those who may be exposed to the virus at work are recommended to get vaccinated.

In September, California posted guidance on how to keep workers safe from mpox in the workplace.

Photo credit: Richard H Grant / Shutterstock.com

About the Author

Alex Saurman is a former Content Editor for Occupational Health & Safety,who has since joined OH&S’s client services team. She continues to work closely with OH&S’s editorial team and contributes to the magazine.

Product Showcase

  • SlateSafety BAND V2

    SlateSafety BAND V2

    SlateSafety's BAND V2 is the most rugged, easy-to-use connected safety wearable to help keep your workforce safe and help prevent heat stress. Worn on the upper arm, this smart PPE device works in tandem with the SlateSafety V2 system and the optional BEACON V2 environmental monitor. It includes comprehensive, enterprise-grade software that provides configurable alert thresholds, real-time alerts, data, and insights into your safety program's performance all while ensuring your data is secure and protected. Try it free for 30 days. 3

Featured

Webinars